AI researcher in front of screen with data points

Artificial Intelligence is Helping Deliver Cancer Outcomes Better than the National Average

Nowhere are we exploring AI, and its subcategory machine learning (ML), with more important consequences than the field of oncology.

a graphic representing AI machine learning

Why We Built the First Machine Learning Department in Oncology

The resurgence of AI and its machine learning algorithms has created tremendous excitement for AI/ML prospects in cancer research.

The Future of Ovarian Cancer Treatment with Antibody-Drug Conjugates (ADCs)

The relentless pursuit of improving treatment for ovarian cancer has led to better outcomes and created new standards of care for ovarian cancer.

Chimeric RNAs Reveal Putative Neoantigen Peptides for Developing Tumor Vaccines for Breast Cancer

Dr. Brian Czerniecki, chair of the Breast Oncology Program, co-authored the publication, “Chimeric RNAs reveal putative neoantigen peptides for...

Response Assessment in Neuro-Oncology Criteria for Gliomas

Dr. Michael Vogelbaum co-authored a publication entitled, “RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and...

Balancing Benefits and Toxicity of Immunotherapy in Melanoma

Drs. Peter Forsyth and Muhammad Jaffer co-authored the publication entitled, “A Brain, A Heart, and the Courage: Balancing Benefit and Toxicity of...

Dr. Vogelbaum and Etame in the operating room

Improving Brain Metastases Outcomes Through SRS and Targeted Therapies

Members of the Neuro-Oncology team co-authored a publication entitled, “Improving Brain Metastases Outcomes Through Therapeutic Synergy Between...

Impact of Surgical Margin and Extent of Lymphadenectomy on Oncologic Outcomes in Plasmacytoid Urothelial Carcinoma

“Impact of Surgical Margin and Extent of Lymphadenectomy on Oncologic Outcomes in Plasmacytoid Urothelial Carcinoma” explores guideline...

Immunotherapy in the Treatment of Localized Genitourinary Cancers

Urologists in the Department of Genitourinary Oncology co-authored the publication, "Immunotherapy in the Treatment of Localized Genitourinary...

Certificate for Dr. Dan Fernandez Recognized as Center of Excellence for SpaceOAR Hydrogel

Dr. Fernandez SpaceOAR Hydrogel Center of Excellence Recognition

Radiation oncologist Dr. Dan Fernandez has been designated as a Center of Excellence for SpaceOAR™ Hydrogel.

Doctors in the GU Department discuss a case

Revisiting Mechanisms of Resistance to Immunotherapies in Metastatic Clear-Cell Renal-Cell Carcinoma

Urologists in the Department of Genitourinary Oncology co-authored a publication entitled “Revisiting mechanisms of resistance to immunotherapies in...

How the IPOP Service Is Shaping the Standard of Care in Infusion Centers

The IPOP provides a new way for patients to receive the chemotherapy infusions they need in the comfort of an outpatient setting.

Impacts of Socioeconomic Status and Cancer Care

Arnold Etame, a neurosurgeon and research scientist in the Department of Neuro-Oncology, discusses how socioeconomic status can impact cancer...

Dr. Kirtane screening patient for head and neck cancer

Testing Metformin for Oral Cancer Prevention

The objective of clinical trial MCC 21940 is to help researchers determine the historical response to metformin intervention that can stop changes in...